Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non­Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast.

Le, Xiuning; Nadler, Eric; Costa, Daniel B; Heymach, John Victor

Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic NonSmall Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast.

Le, Xiuning; Nadler, Eric; Costa, Daniel B; Heymach, John Victor.

Afiliación

Le X; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. xle1@mdanderson.org.
Nadler E; Baylor University Medical Center, Dallas, TX, USA.
Costa DB; Division of Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Heymach JV; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Target Oncol ; 19(1): 125, 2024 Jan.

Article en En | MEDLINE | ID: mdl-38070005

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Target Oncol Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Francia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google